Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Atypical femoral fracture risk in patients treated with bisphosphonates.

Bauer DC.

Arch Intern Med. 2012 Jun 25;172(12):936-7. doi: 10.1001/archinternmed.2012.1827. No abstract available.

2.

Highly different risk estimates for atypical femoral fracture with use of bisphosphonates - debate must be allowed!

Rydholm A.

Acta Orthop. 2012 Aug;83(4):319-20. doi: 10.3109/17453674.2012.718517. Epub 2012 Aug 20. No abstract available.

3.

Increasing occurrence of atypical femoral fractures associated with bisphosphonate use.

Meier RP, Perneger TV, Stern R, Rizzoli R, Peter RE.

Arch Intern Med. 2012 Jun 25;172(12):930-6. doi: 10.1001/archinternmed.2012.1796.

PMID:
22732749
4.

[Is SSBT associated with atypical femoral fracture? SSBT isn't associated with atypical femoral fracture].

Soen S.

Clin Calcium. 2012 Jun;22(6):919-22. doi: CliCa1206919922. Japanese.

PMID:
22653034
5.

Atypical femur fractures associated with use of bisphosphonates and denosumab.

Farooki A, Fornier M, Boland P.

Ann Oncol. 2015 Apr;26(4):819-20. doi: 10.1093/annonc/mdv014. Epub 2015 Jan 20. No abstract available.

6.

Risk of atypical femoral fractures and osteonecrosis of the jaw associated with alendronate use compared with other oral bisphosphonates.

Kharazmi M, Hallberg P, Warfvinge G, Michaëlsson K.

Rheumatology (Oxford). 2014 Oct;53(10):1911-3. doi: 10.1093/rheumatology/keu286. Epub 2014 Aug 6. No abstract available.

7.

Atypical bilateral femoral shaft fracture in patient treated with bisphosphonates.

Parrón Cambero R, Rey López A, Tomé-Bermejo F, Cibantos Martínez R.

Eur J Orthop Surg Traumatol. 2013 Nov;23 Suppl 2:S219-23. doi: 10.1007/s00590-012-1086-9. Epub 2012 Sep 27.

PMID:
23412218
8.

Atypical femoral fractures: what do we know about them?: AAOS Exhibit Selection.

Unnanuntana A, Saleh A, Mensah KA, Kleimeyer JP, Lane JM.

J Bone Joint Surg Am. 2013 Jan 16;95(2):e8 1-13. doi: 10.2106/JBJS.L.00568. Review. No abstract available.

PMID:
23324969
9.

[Atypical femoral fracture associated with the use of bisphosphonates, an adverse drug reaction not to be missed].

Ing Lorenzinit K, Meier R, Suva D, Dayer P, Desmeules J, Peter R.

Rev Med Suisse. 2012 Jun 6;8(344):1238-42. Review. French.

PMID:
22730621
10.

Questioning the association between bisphosphonates and atypical femoral fractures.

Pazianas M, Kim SM, Yuen T, Sun L, Epstein S, Zaidi M.

Ann N Y Acad Sci. 2015 Jan;1335:1-9. doi: 10.1111/nyas.12551. Epub 2014 Oct 7. Review.

11.

Atypical subtrochanteric and femoral shaft fractures and possible association with bisphosphonates.

Nieves JW, Cosman F.

Curr Osteoporos Rep. 2010 Mar;8(1):34-9. doi: 10.1007/s11914-010-0007-2. Review.

PMID:
20425089
12.

Review: epidemiology and pathophysiology of atypical femur fractures.

Ng AC, Png MA, Chua DT, Koh JS, Howe TS.

Curr Osteoporos Rep. 2014 Mar;12(1):65-73. doi: 10.1007/s11914-014-0198-z. Review.

PMID:
24526234
13.

Atypical femoral fractures and bisphosphonate treatment: experience in two large United Kingdom teaching hospitals.

Thompson RN, Phillips JR, McCauley SH, Elliott JR, Moran CG.

J Bone Joint Surg Br. 2012 Mar;94(3):385-90. doi: 10.1302/0301-620X.94B3.27999.

PMID:
22371548
14.

Burden of bisphosphonate-associated femoral fractures.

Shkolnikova J, Flynn J, Choong P.

ANZ J Surg. 2013 Mar;83(3):175-81. doi: 10.1111/ans.12018. Epub 2012 Dec 6.

PMID:
23216704
15.

Atypical femoral fractures, bisphosphonates, and mechanical stress.

Aspenberg P, Schilcher J.

Curr Osteoporos Rep. 2014 Jun;12(2):189-93. doi: 10.1007/s11914-014-0200-9.

PMID:
24615358
16.

Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy.

Chang ST, Tenforde AS, Grimsrud CD, O'Ryan FS, Gonzalez JR, Baer DM, Chandra M, Lo JC.

Bone. 2012 Sep;51(3):524-7. doi: 10.1016/j.bone.2012.05.010. Epub 2012 May 23.

PMID:
22634175
17.

Bisphosphonate-associated atypical subtrochanteric femur fractures in the older patient.

Gopal GK, Tam KL, Krishnan SP, Maddern IL.

N Z Med J. 2014 Feb 14;127(1389):81-5.

PMID:
24548959
18.

Femoral insufficiency fractures with bisphosphonate therapy. Cases study.

Boszczyk A, Kowalski D, Zakrzewski P, Pomianowski S.

Ortop Traumatol Rehabil. 2011 Jul-Aug;13(4):403-8. English, Polish.

PMID:
21857071
19.

Atypical femoral fractures associated with long-term bisphosphonate use.

Chatterjee S.

CMAJ. 2013 Oct 1;185(14):1248. doi: 10.1503/cmaj.121698. Epub 2013 May 6. No abstract available.

20.

Bisphosphonates and atypical femoral fractures.

Hofbauer LC, Jakob F, Felsenberg D.

N Engl J Med. 2010 Sep 9;363(11):1084; author reply 1084-5. No abstract available.

PMID:
20848679
Items per page

Supplemental Content

Write to the Help Desk